Claritin Maker Sued Over Ads

The countdown to Brandweek is on! Join us, Sept. 12-16, to identify new growth opportunities, solve challenges and connect with power players. View the lineup and secure your pass.

WASHINGTON–A Boston consumer group filed a class-action suit Thursday against Schering-Plough Corporation, the maker of Claritin, alleging the company has used deceptive and unfair advertising to increase demand for the drug.

The Prescription Access Litigation Project filed the suit in Superior Court in New Jersey. “We believe Schering-Plough has deliberately left out any information about the drug?s efficacy, instead serving up glowing ads to push this product in America?s living rooms,” said Stephen Rosenfeld, the group’s spokesman.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in